PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-06-12

Date Title Company
12-Jun-2024 Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions Newswire
12-Jun-2024 Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions AccessWire
12-Jun-2024 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
12-Jun-2024 Nava Health Begins Construction on First Boston-Area Location; New Center in Chestnut Hill Will Provide Personalized Functional and Longevity Medicine AccessWire
12-Jun-2024 Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024 AccessWire
12-Jun-2024 Imbiotechnologies Signs Supply Agreement With Medicus Management AccessWire
12-Jun-2024 Clearstep Unveils Advanced Self-Service Booking for Specialist Care AccessWire
12-Jun-2024 Rutherrin(R) Increases Efficacy of Chemotherapy AccessWire
12-Jun-2024 Botanical Supplements Market to Exceed $95.7 Billion by 2033 with 3% CAGR: FMI Report MARKITWIRED
12-Jun-2024 Collagen Supplement Market Set to Hit $3,089.7 Million by 2034 on Rising Healthcare Spend MARKITWIRED
12-Jun-2024 CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT CluePoints
12-Jun-2024 Scottish Medicines Consortium (SMC) Approves First Subcutaneous Bispecific Treatment Option Tepkinly®▼(epcoritamab) for Adults with an Aggressive Form of Blood Cancer After Two or More Lines of Systemic Therapy AbbVie
12-Jun-2024 Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by its Service Provider Seqens AccessWire
12-Jun-2024 MindBio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial AccessWire
12-Jun-2024 Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens Biophytis
12-Jun-2024 Waters | Wyatt Technology Forms a Strategic Collaboration With Bioz to Promote Scientific Discovery by Leveraging Publications AccessWire
12-Jun-2024 BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patients BellaSeno GmbH
12-Jun-2024 GenomesDAO Secures New Investment Round From Pantera Capital and Modular Capital AccessWire
12-Jun-2024 Global Alexipharmic Drug Market is expected to reach USD 6.50 Billion by 2034 MARKITWIRED
12-Jun-2024 Genflow Biosciences PLC Announces Receipt of Grant Funding AccessWire